Propanc Biopharma (PPCB) Change in Account Payables (2011 - 2025)
Propanc Biopharma (PPCB) posted quarterly Change in Account Payables of -$123564.0 for Q4 2025, down 201.97% year-over-year from $121171.0 in Q4 2024, and up 33.85% quarter-over-quarter from -$186804.0 in Q3 2025.
Propanc Biopharma (PPCB) Change in Account Payables (2011 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Change in Account Payables for 15 consecutive years, with -$123564.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Account Payables fell 201.97% year-over-year to -$123564.0; the TTM figure through Dec 2025 stood at -$225010.0 (down 228.27% YoY), while the FY2025 annual figure was $187732.0, down 22.56% from the prior year.
- Change in Account Payables climbed to -$123564.0 in Q4 2025 per PPCB's latest filing, from -$186804.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $148834.0 in Q3 2023 and bottomed at -$186804.0 in Q3 2025.
- Historically, Change in Account Payables has averaged $16009.0 across 5 years, with a median of $26827.0 in 2021.
- On a YoY basis, Change in Account Payables climbed as much as 119110.34% in 2025 and fell as far as 893.8% in 2025.
- Propanc Biopharma's Change in Account Payables stood at $86890.0 in 2021, then plunged by 140.97% to -$35601.0 in 2022, then surged by 157.65% to $20525.0 in 2023, then surged by 490.36% to $121171.0 in 2024, then plunged by 201.97% to -$123564.0 in 2025.
- Business Quant data shows PPCB's Change in Account Payables at -$123564.0 in Q4 2025, -$186804.0 in Q3 2025, and $69026.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - | -123,564.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -123,564.00 |
| Dec 31, 2025 | -123,564.00 |
| Sep 30, 2025 | -186,804.00 |
| Sep 30, 2025 | -186,804.00 |
| Jun 30, 2025 | 69,026.00 |
| Jun 30, 2025 | 69,026.00 |
| Mar 31, 2025 | 16,332.00 |
| Mar 31, 2025 | 16,332.00 |
| Dec 31, 2024 | 121,171.00 |
| Dec 31, 2024 | 121,171.00 |
| Sep 30, 2024 | -18,797.00 |
| Sep 30, 2024 | -18,797.00 |
| Jun 30, 2024 | -58.00 |
| Jun 30, 2024 | -58.00 |
| Mar 31, 2024 | 73,107.00 |
| Mar 31, 2024 | 73,107.00 |
| Dec 31, 2023 | 20,525.00 |
| Dec 31, 2023 | 20,525.00 |
| Sep 30, 2023 | 148,834.00 |
| Sep 30, 2023 | 148,834.00 |